Iovance Biotherapeutics Inc. Common Stock vs Rio Tinto (ADR) — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $13.52 (market cap $5.85B), while Rio Tinto (ADR) trades at $94.2 (market cap $151.50B). The key difference: Rio Tinto (ADR) is far larger — about 25.9× Iovance Biotherapeutics Inc. Common Stock's market cap, and Rio Tinto (ADR) pays a 4.99% dividend while Iovance Biotherapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and Rio Tinto (ADR) for 10 Days on average.
| IOVA | RIO | |
|---|---|---|
Market Cap | $5.85B | $151.50B |
Volume | 14,517,176 | 2,164,712 |
Sector | Health | Basic Materials |
52-Week High | $14.82 | $112.04 |
52-Week Low | $1.81 | $65.44 |
Typical Hold Time | 0 Days | 10 Days |
Enterprise Value | $5.78B | $164.84B |
Dividend Yield | — | 4.99% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →Rio Tinto is a global mining company that produces metals and minerals including iron ore, aluminium, copper, and lithium. Its operations supply materials used in construction, manufacturing, transportation, and energy systems.
Read more on RIO →